Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$367M |
| 2 |
Aon
AON
|
+$334M |
| 3 |
Cigna
CI
|
+$316M |
| 4 |
Comcast
CMCSA
|
+$311M |
| 5 |
Analog Devices
ADI
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$522M |
| 2 |
Visa
V
|
+$494M |
| 3 |
JPMorgan Chase
JPM
|
+$425M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$415M |
| 5 |
Broadcom
AVGO
|
+$390M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.68% |
| 2 | Technology | 16.39% |
| 3 | Healthcare | 14.57% |
| 4 | Industrials | 13.2% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
United Therapeutics
UTHR
$25.7B
| $2.05M | ﹤0.01% |
18,224
+9,801
| +116% | +$1.25M |
|
|
AEL
702
DELISTED
American Equity Investment Life Holding Company
AEL
| $2.02M | ﹤0.01% |
68,719
+1,793
| +3% | +$57.4K |
|
703
Ternium
TX
$9.76B
| $2M | ﹤0.01% |
61,421
-3,207
| -5% | -$109K |
|
704
Integer Holdings
ITGR
$4.23B
| $1.96M | ﹤0.01% |
34,735
+913
| +3% | +$46K |
|
|
AVNS
705
DELISTED
Avanos Medical
AVNS
| $1.91M | ﹤0.01% |
41,344
+639
| +2% | +$30.3K |
|
|
DCOY
706
Decoy Therapeutics
DCOY
$2.31M
| – | – |
0
| – | – |
|
707
vTv Therapeutics
VTVT
$128M
| $1.85M | ﹤0.01% |
11,389
+117
| +1% | +$28.6K |
|
708
Cemex
CX
$17.1B
| $1.83M | ﹤0.01% |
276,444
-5,969
| -2% | -$44.7K |
|
709
Banco Macro
BMA
$5.93B
| $1.81M | ﹤0.01% |
16,747
+10,077
| +151% | +$1.09M |
|
710
ENI
E
$79B
| $1.77M | ﹤0.01% |
50,136
+1,646
| +3% | +$57.1K |
|
711
CONMED
CNMD
$1.55B
| $1.74M | ﹤0.01% |
27,484
-16,817
| -38% | -$1M |
|
712
Enova International
ENVA
$6.44B
| $1.71M | ﹤0.01% |
77,414
+4,081
| +6% | +$82.1K |
|
|
AMAG
713
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.64M | ﹤0.01% |
81,564
+1,485
| +2% | +$25.1K |
|
714
Regional Management Corp
RM
$324M
| $1.64M | ﹤0.01% |
51,393
+5,964
| +13% | +$176K |
|
715
Western Alliance Bancorporation
WAL
$9.04B
| $1.61M | ﹤0.01% |
27,673
+427
| +2% | +$25.3K |
|
|
AVTA
716
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.6M | ﹤0.01% |
65,252
+1,040
| +2% | +$24.7K |
|
717
Bloomin' Brands
BLMN
$774M
| $1.6M | ﹤0.01% |
65,736
+1,046
| +2% | +$23.7K |
|
718
Banco Santander Chile
BSAC
$16.4B
| $1.58M | ﹤0.01% |
47,128
-1,303
| -3% | -$43.2K |
|
719
Jefferies Financial Group
JEF
$12.8B
| $1.57M | ﹤0.01% |
77,426
+19,530
| +34% | +$443K |
|
|
BEAT
720
DELISTED
BioTelemetry, Inc.
BEAT
| $1.55M | ﹤0.01% |
49,833
+898
| +2% | +$29.5K |
|
|
JNPR
721
DELISTED
Juniper Networks
JNPR
| $1.51M | ﹤0.01% |
62,186
+1,511
| +2% | +$40.2K |
|
722
Brinker International
EAT
$9.66B
| $1.51M | ﹤0.01% |
41,896
-2,041
| -5% | -$74.2K |
|
|
JOYY
723
JOYY Inc
JOYY
$3.73B
| $1.5M | ﹤0.01% |
+14,301
| New | +$1.8M |
|
724
Gold Fields
GFI
$30.4B
| $1.49M | ﹤0.01% |
369,386
+343,643
| +1,335% | +$1.4M |
|
725
Jabil
JBL
$33.4B
| $1.46M | ﹤0.01% |
50,712
+800
| +2% | +$21.8K |
|
Similar funds
Massachusetts Financial Services's Q1 2018 Portfolio in Review
As of Q1 2018, Massachusetts Financial Services held 906 positions worth $233B, down 2.2% from $239B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Massachusetts Financial Services's Q1 2018 filing shows 64 new, 428 increased, 336 reduced and 72 closed positions. Its largest new stake was Vertex Pharmaceuticals: 1,519,822 shares worth $248M. The largest sale was Accenture, an estimated $522M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.
- Massachusetts Financial Services's largest Q1 2018 buy was Vertex Pharmaceuticals: 1,519,822 shares worth $248M.
- Massachusetts Financial Services added most to Altria Group in Q1 2018, an estimated $367M increase.
- Massachusetts Financial Services's biggest Q1 2018 reduction was Accenture, cutting an estimated $522M.
- Massachusetts Financial Services fully exited FMC in Q1 2018, selling an estimated $140M.
- Massachusetts Financial Services's ten largest holdings make up 18% of its $233B portfolio in Q1 2018.
- Massachusetts Financial Services opened 64 new positions and closed 72 in Q1 2018.
- Massachusetts Financial Services's portfolio value fell 2.2% quarter-over-quarter to $233B.
Based on Massachusetts Financial Services's 13F filing for Q1 2018, filed 4 May 2018.